Ledipasvir and sofosbuvir for 12 weeks for hepatitis C virus genotype 2 infection: A propensity score matched analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ledipasvir and sofosbuvir for 12 weeks for hepatitis C virus genotype 2 infection: A propensity score matched analysis

Published:2019-11-19 Issue:2 Volume:50 Page:174-181
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Ogawa Eiichi¹,Nomura Hideyuki²³,Nakamuta Makoto⁴,Kawano Akira⁵,Dohmen Kazufumi⁶,Kajiwara Eiji⁷,Satoh Takeaki⁸,Koyanagi Toshimasa⁹,Takahashi Kazuhiro¹⁰,Ooho Aritsune¹¹,Azuma Koichi¹²,Furusyo Norihiro¹,Kato Masaki¹³,Shimoda Shinji¹⁴,Hayashi Jun¹⁵,

Affiliation:

1. Department of General Internal MedicineKyushu University Hospital Fukuoka Japan

2. The Center for Liver DiseaseShin‐Kokura Hospital Kitakyushu Japan

3. Department of MedicineHaradoi Hospital Fukuoka Japan

4. Department of Gastroenterology, Kyushu Medical CenterNational Hospital Organization Fukuoka Japan

5. Department of MedicineKitakyushu Municipal Medical Center Kitakyushu Japan

6. Department of Internal MedicineChihaya Hospital Fukuoka Japan

7. Kajiwara Clinic Kitakyushu Japan

8. Center for Liver DiseaseKokura Medical Center Kitakyushu Japan

9. Department of MedicineFukuoka City Hospital Fukuoka Japan

10. Department of MedicineHamanomachi Hospital Fukuoka Japan

11. Department of HepatologySteel Memorial Yawata Hospital Kitakyushu Japan

12. Department of MedicineKyushu Central Hospital Fukuoka Japan

13. Department of Medicine and Bioregulatory Science, Graduate School of Medical SciencesKyushu University Fukuoka Japan

14. Department of Medicine and Biosystemic Science, Graduate School of Medical SciencesKyushu University Fukuoka Japan

15. Kyushu General Internal Medicine CenterHaradoi Hospital Fukuoka Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13437

Reference25 articles.

1. Hepatitis C Virus Infection

2. Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence

3. Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection

4. Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System

5. Systematic review with meta-analysis: effectiveness and tolerability of interferon-free direct-acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Glecaprevir/Pibrentasvir and Sofosbuvir/Ledipasvir in Patients with Hepatitis C Virus Genotype 1 and 2 in South Korea;The Korean Journal of Gastroenterology;2024-03-25

2. Efficacy and safety of direct‐acting antiviral therapy for hepatitis C virus in elderly patients (≥65 years old): A systematic review and meta‐analysis;Journal of Viral Hepatitis;2022-04-06

3. Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis;Indian Journal of Gastroenterology;2022-03-12

4. Changes in the serum metabolomic profiles of subjects with NAFLD in response to n-3 PUFAs and phytosterol ester: a double-blind randomized controlled trial;Food & Function;2022

5. Alleviating the effect of quinoa and the underlying mechanism on hepatic steatosis in high-fat diet-fed rats;Nutrition & Metabolism;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3